Medagama Arjuna B, Bandara Ruwanthi
Department of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Nutr J. 2014 Oct 21;13:102. doi: 10.1186/1475-2891-13-102.
Diabetes mellitus is a major cause of morbidity and mortality worldwide, with a prevalence of 347 million in 2013. Complementary and Alternative Medicines (CAM) are a group of remedies that is fast gaining acceptance among individuals. Cinnamon, Bitter gourd (Momordica charantia) and Fenugreek (Trigonella foenum-graecum) are 3 widely used CAMs used worldwide for the treatment of diabetes. Data on safety and efficacy is limited, but the consumption is wide. Crepe ginger (Costus speciosus) and Ivy gourd (Coccinia grandis) are 2 plants used widely in the Asian region for their presumed hypoglycaemic properties.
In this review, we analyzed the available evidence for the 5 CAMs mentioned above in terms of in-vitro studies, animal studies sand clinical trials. We also describe the mechanisms of hypoglycaemia and safety concerns where there is available evidence.
Clinical trials that studied the hypoglycaemic effects of Cinnamon, bitter gourd, fenugreek and ivy gourd showed conflicting results. Direct comparison between studies remains a challenge in view of the baseline heterogeneity of subjects, differences in substrate preparation, variable end points and poor trial design. Short durations of study and small number of subjects studied is universal. Crepe ginger has not been studied adequately in humans to draw conclusions.In view of the high prevalence of use and safety and efficacy issues, there is an urgent need to study their hypoglycaemic and adverse effects in well-designed long-term clinical trials.
糖尿病是全球发病和死亡的主要原因,2013年全球患病率达3.47亿。补充和替代医学(CAM)是一类正迅速获得人们认可的疗法。肉桂、苦瓜和葫芦巴是全球广泛用于治疗糖尿病的三种补充和替代医学疗法。关于其安全性和有效性的数据有限,但使用广泛。闭鞘姜和印度南瓜是亚洲地区因其假定的降血糖特性而广泛使用的两种植物。
在本综述中,我们根据体外研究、动物研究和临床试验分析了上述五种补充和替代医学疗法的现有证据。我们还描述了有证据时的降血糖机制和安全问题。
研究肉桂、苦瓜、葫芦巴和印度南瓜降血糖作用的临床试验结果相互矛盾。鉴于受试者的基线异质性、底物制备差异、可变终点和不良试验设计,研究之间的直接比较仍然是一个挑战。研究持续时间短和研究对象数量少是普遍现象。闭鞘姜在人体中的研究尚不充分,无法得出结论。鉴于其高使用率以及安全性和有效性问题,迫切需要在设计良好的长期临床试验中研究它们的降血糖作用和不良反应。